nazwa: Enavatuzumab
nr katalogowy: GC69062-1
cas: 1062149-33-0
producent: GLPBio
opakowanie: 1mg
cena: 1678,24 [Pln] (bez rabatu)
wyszukaj podobne produkty: 1062149-33-0
Storage: Store at -20°C. Synonym: Enavatuzumab (PDL192, ABT-361) is a humanized IgG1 monoclonal antibody that targets the TNF-like weak inducer of apoptosis receptor (TWEAK). TWEAK (Fn14, TNFRSF12A) is the natural ligand for the TweakR receptor and can stimulate various cellular responses. Enavatuzumab induces tumor growth inhibition through direct TweakR signaling and antibody-dependent cell-mediated cytotoxicity (ADCC). Enavatuzumab actively recruits and activates bone marrow effector cells to kill tumor cells. In vitro and in vivo, enavatuzumab inhibits the growth of various human TweakR-positive cancer cell lines and xenografts..
czystość: No data
czas dostawy: Do potwierdzenia przez Chemat